You have 9 free searches left this month | for more free features.

City

Honolulu (1)

Osaka (1)

Oslo (1)

Phoenix (1)

Salt Lake City (1)

Tokyo (1)

Condition

Aldehyde Dehydrogenase-2 (ALDH2) Deficiency (1)

Ethylene Glycol Poisoning, Methanol Poisoning (1)

Healthy Adult Volunteers (1)

Macular Dystrophy, Corneal (1)

Toxic Alcohol Poisoning (1)

Overall Status

Completed (4)

Unknown status (1)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

phase 2 (1)

Sponsor

Horizon Pharma USA, Inc. (1)

Oslo University Hospital (1)

Takeda (1)

University of Arizona (1)

University of Utah (1)

Collaborator

Louisiana State University Health Sciences Center Shreveport (1)

Intervention

fomepizole (2)

4-methylpyrazole (1)

antizol (1)

apap (1)

ethanol (1)

placebo (1)

saline (1)

Study Documents

Intervention Type

drug (4)

other (2)

Funder Type

Other (3)

Industry (2)

Study Type

Interventional (3)

Observational (2)

Fomepizole

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Fomepizole Intravenous Infusion (All-case Surveillance)

Completed

Ethylene Glycol Poisoning, Methanol Poisoning

Fomepizole

Osaka, Japan
+1 more

Jul 12, 2022

Fomepizole Dosing During Continuous Renal Replacement Therapy

Unknown status

Toxic Alcohol Poisoning

Oslo, Norway

Oslo University Hospital

Nov 24, 2020

Healthy Adult Volunteers Trial in Phoenix (Fomepizole, APAP)

Completed

Healthy Adult Volunteers

Fomepizole
APAP

Phoenix, Arizona

BUMCP - Department of Medical Toxicology

Sep 24, 2019

Macular Dystrophy, Corneal Trial in Salt Lake City (4-Methylpyrazole, saline)

Completed

Macular Dystrophy, Corneal

4-Methylpyrazole
saline

Salt Lake City, Utah

Moran Eye Center, University of Utah

Aug 3, 2020

Aldehyde Dehydrogenase-2 (ALDH2) Deficiency Trial in Honolulu (Antizol, Placebo, Ethanol)

Completed

Aldehyde Dehydrogenase-2 (ALDH2) Deficiency

Antizol
+2 more

Honolulu, Hawaii

Covance Honolulu CRU

Aug 16, 2017